Allenvik

ZOM looking for some gains.

ロング
AMEX:ZOM   Zomedica Corp.
With a clear breakout, and with its new TRUFORMA product, almost ready for commercialization, ZOM is finally showing some strength that I think will persist for Q3 and Q4 of 2021, taking the stock to way higher prices.
The immediate target is the 15 cents level, and then the 20 cents level, watch these. If these higher levels are taken, the stock could see a fast rise to levels unseen since 2018-2019.
免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。